SpectraCure AB (publ) (SPEC.ST)

SEK 3.59

(15.81%)

Market Cap (In SEK)

348.7 Million

Revenue (In SEK)

318 Thousand

Net Income (In SEK)

-20.44 Million

Avg. Volume

57.36 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.829-5.11
PE
-
EPS
-
Beta Value
0.712
ISIN
SE0007158118
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Dr. Masoud Khayyami Ph.D.
Employee Count
-
Website
https://www.spectracure.com
Ipo Date
2015-07-01
Details
SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.